Co-Authors
This is a "connection" page, showing publications co-authored by Alessandra Vecchié and Aldo Bonaventura.
Connection Strength
3.167
-
High-dose dexamethasone treatment for COVID-19 severe acute respiratory distress syndrome: a retrospective study. Intern Emerg Med. 2021 10; 16(7):1913-1919.
Score: 0.239
-
The role of IL-6 and IL-6 blockade in COVID-19. Expert Rev Clin Immunol. 2021 06; 17(6):601-618.
Score: 0.237
-
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021 05; 21(5):319-329.
Score: 0.235
-
IL-18 and infections: Is there a role for targeted therapies? J Cell Physiol. 2021 03; 236(3):1638-1657.
Score: 0.224
-
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies. Front Immunol. 2020; 11:1625.
Score: 0.223
-
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study. Cancer Immunol Immunother. 2019 Aug; 68(8):1351-1358.
Score: 0.208
-
In-Hospital Initiation of Sacubitril/Valsartan: A New PARADIGM for Acute Decompensated Heart Failure? J Cardiovasc Pharmacol. 2019 07; 74(1):1-3.
Score: 0.208
-
Baseline neutrophil-to-lymphocyte ratio is associated with long-term T2D remission after metabolic surgery. Acta Diabetol. 2019 Jul; 56(7):741-748.
Score: 0.205
-
C-Reactive Protein Levels at the Midpregnancy Can Predict Gestational Complications. Biomed Res Int. 2018; 2018:1070151.
Score: 0.198
-
Obesity phenotypes and their paradoxical association with cardiovascular diseases. Eur J Intern Med. 2018 02; 48:6-17.
Score: 0.188
-
The Pathophysiological Role of Neutrophil Extracellular Traps in Inflammatory Diseases. Thromb Haemost. 2018 01; 118(1):6-27.
Score: 0.187
-
Lung Function and Symptoms in Post-COVID-19 Patients: A Single-Center Experience. Mayo Clin Proc Innov Qual Outcomes. 2021 Oct; 5(5):907-915.
Score: 0.060
-
Use of placebo in clinical trials in COVID-19 pandemic times: considerations on pros, cons, challenges and limitations. Minerva Med. 2021 Jul 16.
Score: 0.060
-
Clinical trial enrollment at a rural satellite hospital during COVID-19 pandemic. J Clin Transl Sci. 2021; 5(1):e136.
Score: 0.059
-
Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Rheumatol. 2021 Jun; 3(6):e410-e418.
Score: 0.058
-
Cardiology on the cutting edge: updates from the European Society of Cardiology (ESC) Congress 2020. BMC Cardiovasc Disord. 2020 10 19; 20(1):448.
Score: 0.057
-
Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19). J Cardiovasc Pharmacol. 2020 05; 75(5):359-367.
Score: 0.055
-
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer. Clin Exp Metastasis. 2019 10; 36(5):449-456.
Score: 0.052
-
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases. Eur J Clin Invest. 2018 Oct; 48(10):e13002.
Score: 0.049
-
Serum PCSK9 levels predict the occurrence of acute coronary syndromes in patients with severe carotid artery stenosis. Int J Cardiol. 2018 07 15; 263:138-141.
Score: 0.049
-
Serum levels of osteopontin predict major adverse cardiovascular events in patients with severe carotid artery stenosis. Int J Cardiol. 2018 Mar 15; 255:195-199.
Score: 0.047
-
Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis. Vascul Pharmacol. 2018 03; 102:37-43.
Score: 0.047
-
Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases. Vascul Pharmacol. 2017 12; 99:1-12.
Score: 0.046
-
Erratum to: The Role of Adipocytokines in Coronary Atherosclerosis. Curr Atheroscler Rep. 2017 05; 19(5):21.
Score: 0.045
-
Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin. Compr Physiol. 2017 03 16; 7(2):603-621.
Score: 0.044
-
The Role of Inflammation in Cardiovascular Outcome. Curr Atheroscler Rep. 2017 Mar; 19(3):11.
Score: 0.044
-
The Role of Adipocytokines in Coronary Atherosclerosis. Curr Atheroscler Rep. 2017 02; 19(2):10.
Score: 0.044